With my feeble brain, I'm having trouble following all the discussions about MNTA here. A question I have is why doesn't SNY just lower the cost of their drug--14% doesn't seem like such a horrendouos discount--in order to retain market share, or even lower their drug pricing below Sandoz's, in order to drive Sandoz's generic out of the market?
Because then you'd have an all-out price war and nobody would win with both sides going back and forth lowering prices. Better to optimize profits by not getting into a pricing war.